DEERFIELD, IL -- (Marketwire) -- 02/09/10 -- Takeda Global Research & Development Center,
Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to
study how dexlansoprazole and several other proton pump inhibitors (PPIs)
affect the pharmacokinetics and pharmacodynamics of Plavix (clopidogrel
bisulfate) in healthy subjects. Takeda has been evaluating all ... read more